Europo 5/80 mg
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Medix Pharmaceutical Co., Ltd.
MFDS item code 201801658 · Approved 2018.04.17
This product's status changed to Expired on 2023.04.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
Amlodipine and valsartan are used in combination to effectively lower blood pressure when monotherapy is insufficient for patients with essential hypertension. These two medications control blood pressure through different mechanisms of action, thus enhancing the blood pressure-lowering effect when used together. Consequently, this drug is used to manage blood pressure in cases of essential hypertension that are difficult to control.
The recommended dose of this product is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this product, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, a direct switch to this product may be considered as follows. · 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. · 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. · 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this product (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this product should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this product to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this product have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, therefore it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to the active ingredients or similar class of drugs, women who are pregnant or breastfeeding, and patients with severe renal or liver dysfunction. Patients with insufficient sodium or fluid levels in the body may experience hypotension, so their condition should be carefully assessed before taking this medication, and blood pressure and condition should be monitored closely during treatment. In patients with high potassium levels or those using medications that may increase potassium levels, potassium concentrations should be checked frequently. Patients with kidney issues or those who have undergone kidney transplants should use this medication with caution, as it may affect kidney function. If symptoms of angioedema such as swelling of the face, lips, or tongue occur, discontinue use immediately and do not take it again. Patients with heart failure or post-myocardial infarction may be at risk of worsening kidney function or hypotension when using this medication, so regular monitoring of renal function is necessary. Patients with heart diseases such as acute myocardial infarction or aortic stenosis should exercise caution when using this drug. When used in conjunction with other renin-angiotensin-aldosterone system medications, the risk of hypotension, worsening kidney function, and hyperkalemia may increase, so it is advisable not to use them together. Dizziness or fatigue may occur when driving or operating machinery, caution is advised. Overdosage may lead to hypotension or cardiac rhythm disturbances; in such cases, immediate medical attention is required. The safety and efficacy of this medication in children under 18 years of age have not been sufficiently established and is therefore not recommended.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture ingress, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
Dark yellow round film-coated tablets
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Medix Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.